Evidence map›Paper›PMID 28644897›Full record

ArticlePloS one2017

TRPA1 and TRPV1 contribute to propofol-mediated antagonism of U46619-induced constriction in murine coronary arteries.

Pritam Sinharoy, Ian N Bratz, Sayantani Sinha, Loral E Showalter, Spencer R Andrei, Derek S Damron

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. TRPA1 channel contributes to myocardial ischemia-reperfusion injury.American journal of physiology. Heart and circulatory physiology · 2019
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pritam SinharoyDepartment of Anesthesia, Perioperative and Pain Medicine, Stanford School of Medicine, Stanford, California, United States of America.ORCID http://orcid.org/0000-0002-6322-260X
Ian N BratzDepartment of Integrative Medical Sciences, Northeast Ohio Medical College, Rootstown, Ohio, United States of America.
Sayantani SinhaDepartment of Surgery, Division of Orthopedic Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Loral E ShowalterDepartment of Biological Sciences, Kent State University, Kent, Ohio, United States of America.
Spencer R AndreiDepartment of Biological Sciences, Kent State University, Kent, Ohio, United States of America.
Derek S DamronDepartment of Biological Sciences, Kent State University, Kent, Ohio, United States of America.ORCID http://orcid.org/0000-0002-4709-5241

Funding

Propofol and Protein Kinase C: Molecular Interactions in CardiomyocytesR01HL065701 · NHLBI · KENT STATE UNIVERSITY · PI DAMRON, DEREK SCOTT · 2002 to 2011
$2.7M
NHLBI NIH HHS R01 HL065701
6 · The paper itself

Abstract

backgroundTransient receptor potential (TRP) ion channels have emerged as key components contributing to vasoreactivity. Propofol, an anesthetic is associated with adverse side effects including hypotension and acute pain upon infusion. Our objective was to determine the extent to which TRPA1 and/or TRPV1 ion channels are involved in mediating propofol-induced vasorelaxation of mouse coronary arterioles in vitro and elucidate the potential cellular signal transduction pathway by which this occurs.

methodsHearts were excised from anesthetized mice and coronary arterioles were dissected from control C57Bl/6J, TRPA1-/-, TRPV1-/- and double-knockout mice (TRPAV-/-). Isolated microvessels were cannulated and secured in a temperature-controlled chamber and allowed to equilibrate for 1 hr. Vasoreactivity studies were performed in microvessels pre-constricted with U46619 to assess the dose-dependent relaxation effects of propofol on coronary microvascular tone.

resultsPropofol-induced relaxation was unaffected in vessels obtained from TRPV1-/- mice, markedly attenuated in pre-constricted vessels obtained from TRPA1-/- mice and abolished in vessels obtained from TRPAV-/- mice. Furthermore, NOS inhibition with L-NAME or endothelium denuding abolished the proporfol-induced depressor response in pre-constricted vessels obtained from all mice. In the absence of L-NAME, BKCa inhibition with penitrem A markedly attenuated propofol-mediated relaxation in vessels obtained from wild-type mice and to a lesser extent in vessels obtained from TRPV1-/-, mice with no effect in vessels obtained from TRPA1-/- or TRPAV-/- mice.

conclusionsTRPA1 and TRPV1 appear to contribute to the propofol-mediated antagonism of U46619-induced constriction in murine coronary microvessels that involves activation of NOS and BKCa.

Indexed as

15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidAnimalsCells, CulturedCoronary VesselsEndothelial CellsLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMaleMice, Inbred C57BLMice, KnockoutMicrovesselsNitric Oxide Synthase Type IIIPropofolTransient Receptor Potential ChannelsTRPA1 Cation ChannelTRPV Cation ChannelsVasoconstrictor Agents15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidBKCa protein, mouseLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsNitric Oxide Synthase Type IIINos3 protein, mousePropofolTransient Receptor Potential ChannelsTRPA1 Cation ChannelTrpa1 protein, mouseTRPV1 protein, mouseTRPV Cation ChannelsVasoconstrictor AgentsVasodilator Agents

Identifiers

PMID28644897
PMCPMC5482493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.